Does X4 Pharmaceuticals Inc (XFOR) offer a good opportunity for investors?

With 1.36 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.02 million shares. The 52-week range on XFOR shows that it touched its highest point at $2.58 and its lowest point at $0.57 during that stretch. It currently has a 1-year price target of $3.06. Beta for the stock currently stands at 0.46.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of XFOR was down-trending over the past week, with a drop of -5.48%, but this was up by 36.63% over a month. Three-month performance surged to 64.58% while six-month performance rose 26.61%. The stock gained 54.17% in the past year, while it has gained 64.58% so far this year. A look at the trailing 12-month EPS for XFOR yields -0.60 with Next year EPS estimates of -0.45. For the next quarter, that number is -0.15. This implies an EPS growth rate of 21.30% for this year and 0.00% for next year.

Float and Shares Shorts:

At present, 167.43 million XFOR shares are outstanding with a float of 121.91 million shares on hand for trading. On Mar 15, 2024, short shares totaled 14.22 million, which was 8.49% higher than short shares on Feb 15, 2024. In addition to XFOR as the firm’s X4 Pharmaceuticals, Inc., FOR serves as its Forestar Group Inc.

Institutional Ownership:

Through their ownership of 61.37% of XFOR’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for XFOR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, XFOR has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and XFOR currently yields $0.00. In the past year, XFOR’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, XFOR has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.